0,935  0,002  NOS2 expression inhibitor
0,935  0,005  Apoptosis agonist
0,878  0,004  Antioxidant
0,877  0,003  UGT1A9 substrate
0,847  0,005  Caspase 9 stimulant
0,844  0,004  Free radical scavenger
0,835  0,002  Melanin inhibitor
0,835  0,006  Antineoplastic (breast cancer)
0,815  0,004  AR expression inhibitor
0,786  0,003  Monophenol monooxygenase inhibitor
0,786  0,004  Lipoxygenase inhibitor
0,784  0,007  Antileukemic
0,778  0,006  Chemopreventive
0,779  0,014  Transcription factor NF kappa B inhibitor
0,766  0,005  Nitric oxide antagonist
0,759  0,007  Chemoprotective
0,767  0,020  Antiinflammatory
0,746  0,004  Skin whitener
0,750  0,013  Antineoplastic (lung cancer)
0,714  0,004  Histamine release inhibitor
0,712  0,004  UGT1A1 substrate
0,710  0,010  Respiratory analeptic
0,693  0,009  Antibacterial
0,677  0,005  Antineoplastic (pancreatic cancer)
0,664  0,009  Antineoplastic (cervical cancer)
0,661  0,009  CTGF expression inhibitor
0,660  0,008  Proliferative diseases treatment
0,644  0,008  Antineoplastic (non-small cell lung cancer)
0,644  0,011  CYP2C19 substrate
0,637  0,012  Radioprotector
0,612  0,023  TNF expression inhibitor
0,600  0,016  Streptokinase A inhibitor
0,589  0,007  Antimutagenic
0,584  0,007  Vasodilator
0,581  0,004  NOS3 expression enhancer
0,577  0,013  Cardioprotectant
0,577  0,017  Sensitization
0,578  0,019  Antihypercholesterolemic
0,570  0,014  Cardiovascular analeptic
0,565  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,554  0,022  Angiogenesis inhibitor
0,537  0,005  Antihypotensive
0,540  0,010  UDP-glucuronosyltransferase substrate
0,541  0,018  Analeptic
0,546  0,028  CYP2C9 substrate
0,542  0,027  Antiprotozoal
0,517  0,018  Caspase 3 stimulant
0,531  0,042  Cyclophilin D inhibitor
0,531  0,042  Antidiabetic
0,501  0,015  CYP1A2 inhibitor
0,497  0,020  Antiosteoporotic
0,481  0,006  Lipid peroxidase inhibitor
0,480  0,008  UGT1A3 substrate
0,500  0,027  Bone diseases treatment
0,496  0,026  Antiprotozoal (Plasmodium)
0,489  0,021  NOS3 expression inhibitor
0,476  0,014  Antihypertriglyceridemic
0,467  0,007  Topoisomerase II inhibitor
0,461  0,004  Topoisomerase I inhibitor
0,479  0,023  Cytostatic
0,480  0,025  Antifungal
0,458  0,005  5-Lipoxygenase inhibitor
0,489  0,036  5 Hydroxytryptamine release inhibitor
0,475  0,023  Antineoplastic (glioma)
0,469  0,018  Antiparasitic
0,471  0,034  GABA C receptor rho-3 antagonist
0,439  0,004  Antihemorrhagic
0,467  0,038  Prostate cancer treatment
0,439  0,013  Antihelmintic
0,456  0,033  Antineoplastic (ovarian cancer)
0,424  0,007  Protein-tyrosine phosphatase inhibitor
0,441  0,026  ICAM1 expression inhibitor
0,442  0,029  Antineoplastic (brain cancer)
0,426  0,015  RNA-directed DNA polymerase inhibitor
0,443  0,032  CYP1A2 substrate
0,430  0,020  UGT1A6 substrate
0,460  0,051  15-Lipoxygenase inhibitor
0,444  0,035  CYP2D6 substrate
0,424  0,018  Vascular (periferal) disease treatment
0,415  0,019  Antineoplastic enhancer
0,420  0,024  Hypoglycemic
0,414  0,021  Antihypoxic
0,398  0,013  Hepatoprotectant
0,384  0,006  Protein-tyrosine phosphatase 1B inhibitor
0,423  0,051  CYP2C19 inhibitor
0,419  0,049  Antineoplastic (colorectal cancer)
0,400  0,030  Antiprotozoal (Leishmania)
0,409  0,048  Antineoplastic (colon cancer)
0,385  0,025  Antineoplastic (osteosarcoma)
0,453  0,095  Alpha-glucosidase inhibitor
0,395  0,037  Cytotoxic
0,416  0,058  CYP3A4 substrate
0,394  0,040  Apoptosis antagonist
0,367  0,012  Genotoxic
0,394  0,040  Lipoprotein disorders treatment
0,390  0,042  Spasmolytic
0,377  0,034  Carcinogenic
0,358  0,018  Platelet adhesion inhibitor
0,382  0,044  Antineoplastic (melanoma)
0,349  0,018  UGT2B7 substrate
0,351  0,021  P-glycoprotein inhibitor
0,337  0,013  UGT2B15 substrate
0,328  0,005  Beta glucuronidase inhibitor
0,327  0,005  Estrogen receptor alpha antagonist
0,368  0,050  12-Lipoxygenase inhibitor
0,315  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,307  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,306  0,005  Aromatase inhibitor
0,319  0,019  Antineoplastic (squamous cell carcinoma)
0,319  0,020  VCAM1 expression inhibitor
0,337  0,039  Myocardial infarction treatment
0,329  0,032  Peroxidase inhibitor
0,306  0,016  Protein kinase stimulant
0,294  0,005  Electron transport complex I inhibitor
0,330  0,042  Antineoplastic (renal cancer)
0,365  0,079  Immunosuppressant
0,286  0,005  AMP-activated protein kinase stimulant
0,329  0,050  Antineoplastic (multiple myeloma)
0,337  0,065  Hepatic disorders treatment
0,276  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,273  0,006  Estrogen receptor beta antagonist
0,309  0,043  Amyloid beta aggregation inhibitor
0,310  0,047  Antineoplastic (liver cancer)
0,285  0,022  Neurotrophic factor enhancer
0,280  0,021  Amylase inhibitor
0,305  0,047  Hypolipemic
0,267  0,009  Topoisomerase II alpha inhibitor
0,275  0,018  MAO A inhibitor
0,267  0,012  Antineoplastic antibiotic
0,296  0,048  Antineoplastic (glioblastoma multiforme)
0,257  0,011  Xanthine oxidase inhibitor
0,253  0,008  Estrogen antagonist
0,253  0,009  Breast cancer-resistant protein inhibitor
0,285  0,046  Mutagenic
0,255  0,019  Alkaline phosphatase inhibitor
0,266  0,037  UGT1A4 substrate
0,244  0,016  Cystathionine beta-synthase inhibitor
0,229  0,004  Neuraminidase inhibitor
0,275  0,051  Antiulcerative
0,241  0,019  Cholesterol synthesis inhibitor
0,283  0,064  DNA damaging
0,245  0,029  MAO inhibitor
0,233  0,019  SULT1A3 substrate
0,271  0,061  Angiogenesis stimulant
0,276  0,073  UGT2B4 substrate
0,238  0,035  Antiviral (Herpes)
0,226  0,026  Cyclooxygenase 1 inhibitor
0,273  0,074  Aldehyde oxidase inhibitor
0,221  0,022  DNA polymerase I inhibitor
0,200  0,005  Lipase inhibitor
0,221  0,029  Heat shock protein 90 antagonist
0,235  0,044  Insulin sensitizer
0,299  0,108  Ulceration
0,193  0,003  Retinoic acid alpha receptor agonist
0,264  0,073  Aryl hydrocarbon receptor agonist
0,233  0,054  Antiviral (Influenza)
0,182  0,005  Ornithine decarboxylase inhibitor
0,214  0,037  Antiviral (Influenza A)
0,185  0,009  Estrogen agonist
0,280  0,105  Vasodilator, coronary
0,294  0,120  CYP2C9 inhibitor
0,206  0,031  Acetylcholinesterase inhibitor
0,182  0,013  Phosphodiesterase 4D inhibitor
0,246  0,077  Teratogen
0,181  0,018  Mediator release inhibitor
0,239  0,076  Antiamyloidogenic
0,205  0,043  Antineoplastic (carcinoma)
0,175  0,017  Carbonic anhydrase XIII inhibitor
0,192  0,035  Antifungal enhancer
0,163  0,011  Postmenopausal disorders treatment
0,213  0,062  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,188  0,039  Bone formation stimulant
0,161  0,012  SULT1E1 substrate
0,239  0,095  Transcription factor STAT inhibitor
0,276  0,134  Antiobesity
0,142  0,005  Fatty acid synthase inhibitor
0,144  0,008  Neuraminidase (influenza) inhibitor
0,142  0,011  Aldose reductase inhibitor
0,143  0,014  CDC25A inhibitor
0,164  0,037  DNA intercalator
0,130  0,004  Leukotriene B4 receptor 1 antagonist
0,150  0,025  Dementia treatment
0,127  0,004  Transcription factor RelA inhibitor
0,176  0,053  Interferon gamma antagonist
0,219  0,098  Superoxide dismutase inhibitor
0,227  0,106  Immunostimulant
0,158  0,037  Gout treatment
0,143  0,023  Actinic keratosis treatment
0,155  0,036  Coagulant
0,144  0,025  Vascular dementia treatment
0,208  0,088  Embryotoxic
0,160  0,042  Interleukin 4 antagonist
0,165  0,048  Carcinogenic, group 3
0,191  0,075  CYP2B6 inhibitor
0,181  0,066  Dual specificity phosphatase inhibitor
0,233  0,122  Antimycobacterial
0,133  0,023  Antibiotic
0,182  0,072  LDLR expression enhancer
0,133  0,023  ABCA1 expression enhancer
0,119  0,009  Estrogen receptor beta agonist
0,119  0,011  Ca(v)3.1 blocker
0,163  0,055  Antiacne
0,149  0,041  Glutathione S-transferase substrate
0,155  0,047  Farnesoid X receptor antagonist
0,171  0,064  Arachidonic acid antagonist
0,138  0,032  Multidrug resistance-associated protein 1 inhibitor
0,164  0,058  Antidiarrheal
0,144  0,039  SULT1A1 substrate
0,120  0,015  HIV-1 integrase inhibitor
0,164  0,060  Cyclooxygenase inhibitor
0,124  0,021  Interleukin 5 antagonist
0,197  0,096  Antineoplastic (lymphoma)
0,203  0,105  Antidiabetic symptomatic
0,105  0,008  Estrogen receptor alpha agonist
0,116  0,019  Na+ K+ transporting ATPase inhibitor
0,105  0,009  Leukotriene B4 antagonist
0,152  0,057  Neurotrophic factor
0,151  0,057  Antifungal (Cryptococcus)
0,133  0,043  Mucolytic
0,092  0,004  Retinoic acid receptor agonist
0,229  0,144  Antithrombotic
0,104  0,020  Leukotriene antagonist
0,152  0,070  GABA C receptor rho-2 antagonist
0,121  0,040  Antiviral (Coronavirus)
0,121  0,040  Antiviral (SARS coronavirus)
0,098  0,018  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,120  0,041  Creatine kinase inhibitor
0,134  0,055  Antineoplastic (uterine cancer)
0,138  0,059  Cyclooxygenase 3 inhibitor
0,125  0,048  MAO B inhibitor
0,128  0,052  Antiviral (Influenza B)
0,146  0,075  Antidote
0,099  0,028  Peroxisome proliferator-activated receptor gamma agonist
0,164  0,094  Wound healing agent
0,109  0,039  Thioredoxin inhibitor
0,194  0,126  Antiprotozoal (Trypanosoma)
0,115  0,048  Sulfotransferase substrate
0,120  0,054  Chelator
0,146  0,081  UGT2B9 substrate
0,119  0,059  TRPA1 agonist
0,130  0,070  Cyclooxygenase 2 inhibitor
0,183  0,124  Acute neurologic disorders treatment
0,123  0,066  Growth stimulant
0,129  0,073  NADPH oxidase inhibitor
0,125  0,069  Gastritis treatment
0,088  0,036  SULT1A2 substrate
0,109  0,059  Expectorant
0,109  0,061  Carcinogenic, group 2B
0,105  0,058  Butyrylcholinesterase inhibitor
0,153  0,107  Succinate dehydrogenase inhibitor
0,171  0,125  Antiviral (HIV)
0,177  0,133  Peptidyltransferase inhibitor
0,170  0,126  Platelet antagonist
0,135  0,091  Cholinergic
0,055  0,012  Retinoid X alpha receptor agonist
0,078  0,035  HIV-1 integrase (3'-Processing) inhibitor
0,122  0,081  Antihelmintic (Trematoda)
0,134  0,095  Acute respiratory distress syndrome (ARDS) treatment
0,101  0,062  Anabolic
0,073  0,034  CDC25B inhibitor
0,080  0,042  Antitreponemal
0,064  0,026  Elastase inhibitor
0,120  0,082  Antibacterial (Helicobacter pylori)
0,053  0,017  Retinoid X receptor agonist
0,038  0,005  Leukotriene B4 receptor 2 antagonist
0,072  0,042  Leukotriene synthesis inhibitor
0,095  0,066  UGT2B11 substrate
0,207  0,181  GST M1-1 substrate
0,172  0,147  Nitric-oxide synthase stimulant
0,109  0,084  Antiseptic
0,090  0,065  Uric acid excretion stimulant
0,059  0,034  Pregnane X receptor antagonist
0,142  0,118  UGT2B10 substrate
0,220  0,197  Atherosclerosis treatment
0,130  0,112  Mcl-1 antagonist
0,046  0,030  Neuraminidase (Influenza A) inhibitor
0,061  0,045  Protease activated receptor antagonist
0,101  0,086  Photosensitizer
0,160  0,146  Tumour necrosis factor alpha release inhibitor
0,034  0,020  Estrogen-related receptor beta antagonist
0,141  0,128  Death-associated protein kinase 2 inhibitor
0,038  0,026  Retinoid X receptor antagonist
0,096  0,084  DOPA decarboxylase inhibitor
0,042  0,030  DNA gyrase subunit A inhibitor
0,033  0,021  ATP citrate lysase inhibitor
0,079  0,067  Androgen antagonist
0,116  0,105  Psychosexual dysfunction treatment
0,054  0,047  Leukotriene C antagonist
0,055  0,049  Androgen agonist
0,119  0,114  Eye irritation, high
0,021  0,015  Neuraminidase (Influenza B) inhibitor
0,077  0,072  Thioredoxin reductase inhibitor
0,047  0,045  Glucose-6-phosphate translocase inhibitor
0,069  0,067  Keratolytic
0,017  0,017  Inosine monophosphate dehydrogenase 1 inhibitor

